PharmGen Science, Inc. (KRX:004720)

Market Cap	66.03B -16.9%
Revenue (ttm)	171.66B -0.0%
Net Income	117.75M -98.2%
EPS	6.50 -98.1%
Shares Out	22.61M
PE Ratio	560.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,318
Open	2,920.00
Previous Close	2,920.00
Day's Range	2,920.00 - 3,045.00
52-Week Range	2,590.00 - 5,490.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About PharmGen Science

PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1957 and is headquartered in Hwaseong-si, South Korea.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1957
• Employees: 226
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 004720

Financial Performance

In 2024, PharmGen Science's revenue was 171.29 billion, an increase of 2.70% compared to the previous year's 166.78 billion. Earnings were 2.79 billion, a decrease of -54.17%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 1, 2026

Data Sources Report a data error